Solving academic medical centers' existential crisis statnews.com/2024/04/26/sol… STAT by Ravi Thadhani Emory Healthcare and Anne Klibanski Mass General Brigham

Thank you Pilar Alcaide, PhD and honored to receive this award from American Society for Investigative Pathology and present my work on cardiac inflammation in anthracycline toxicity #pathobiology2024

Thank you Zordoky_Lab for contributing your expertise on Cyp1 enzymes. More to come!

BIDMC CVI Jing Liu Casie Curtin Abul Ariza

Older patients with #Hodgkin #lymphoma have high burden of #HF , high 1 year mortality and low of anthracyclines and cardioprotective meds. Need improved #cardioonc strategies in this population. Check out the latest #JACCCardioOnc issue on anthracyclines
jacc.org/toc/cardio-onc…

Look who was spotted at the American Heart Association: Massachusetts Go Red for Women Celebration in Boston last night!
TY American Heart Association for creating programs that address care gaps of women’s greatest health threat - CVD.

Always fun to share our work with BIDMC Cancer Center. Thank you for the fantastic questions and discussion, and to my lovely host Taru Muranen 🇺🇦!

Congratulations Abul Ariza on your ACC abstract. We are fortunate to have you in our lab BIDMC CVI!

We’re ready for American College of Cardiology #ACC24 ! Participation by CVI & BIDMC colleagues: bit.ly/ACC24-CVI
BIDMC Smith Center BIDMC Department of Medicine BIDMC CV Fellowship

#BIDMC CV Grand Rounds today with clifford jay kavinsky on Transcatheter Tricuspid Valve Therapy: a rapidly changing landscape.
#Structuralheart #TTVR

A wonderful skit (aka roast) night hosted by our truly exceptional and inimitably vibrant second year cardiology fellows! BIDMC CV Fellowship BIDMC CVI

#Cardiotoxity of CAR T-cell Therapy in #MultipleMyeloma

#CardioOncology #IMS24 #Boston

✔️5 to 10% develop cardiomyopathy/ #heartfailure

✔️ #cardiotoxicity associated with adverse outcomes

✔️ Pre CAR T #cardiovascular work up & optimization and close monitoring post CART are…

Generally, less cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib vs. ibrutinib (except for hypertension) Javid Moslehi ashpublications.org/bloodadvances/…

Congratulations to Dr. Robert E. Gerszten, of BIDMC and Harvard Medical School, for being named the 2024 recipient of the Paul Dudley White Award! Dr. Gerszten is being recognized for his outstanding contributions to cardiovascular care. Read more: newsroom.heart.org/local-news/bet…

Welcoming our #Match2024 BIDMC IM Residency class! We're so excited for you to join us from 46 medical schools all across the country and for the expertise you bring in areas such as global health, medical education, quality improvement, and research. Congratulations to all on Match! 🌟🎉

This AHA Science statement is the result of an effort by a multidisciplinary of adult and pediatric experts from around the nation including #CardioOnc and #Hematology to finally bring you evidence-based guidance on the cardiovascular management of patients undergoing BMT.

Extremely happy to share our latest work from the
Eric N. Olson lab! We show that the immunosuppressive PD-1/PD-L1 pathway is active in neonatal mouse hearts and required for regeneration 🫀Huge thanks to co-author Miao Cui and all other authors! nature.com/articles/s4416…

Tremendously excited for this announcement.

Lisa Rosenbaum is one of the most important voices in our profession today.

She'll lead a new effort at BIDMC Smith Center to advance writing and critical thinking in medicine.

Welcome Lisa!

Congratulations to Robert Gerszten on behalf of all of us fellows!! We couldn't be more grateful to have you as our chief.

Congratulations to Dr. Robert Gerszten, Chief of Cardiovascular Medicine BIDMC, recipient of the 2024 American Heart Association: Massachusetts Paul Dudley White Award!